Safety study of two new drugs in healthy men
Part of Kidney & urinary clinical trials.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy man age 19 or older
- Weigh at least 110 pounds (50 kilograms)
- Have a body mass index (BMI) between 18 and 30
- Not have taken part in another drug study in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two versions of a drug to see if they work the same in the body when taken with food. Healthy adult male volunteers are needed.
This trial tests whether two versions of a drug, AD-116A and AD-1161, are equally effective and safe in the body. Healthy adult male volunteers take the drug and have their blood levels compared.
This study tests two new experimental drugs, AD-118 and AD-1181, in healthy adults to see if they are safe and how the body processes them. It helps researchers decide if further testing in patients is possible.
This trial tests two new drugs, AD-118 and AD-1181, to see if they are safe and how the body handles them. It is for healthy volunteers to gather early information before testing in patients.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This study tests whether two versions of the same medication (AJU-G721 and G721R)—used to treat hair loss and urinary symptoms—work the same way in the body. Researchers will measure how much medication gets absorbed and how long it stays in your system.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.